Evidence map›Paper›PMID 40700329›Full record

ArticleInfectious disease reports2025

Erythema Nodosum Leprosum in a Patient with Borderline Lepromatous Leprosy: A Case Report.

Guido Chiriboga, Qianyu Guo, Eric Zuberi, Harry Ross Powers, Libardo Rueda Prada

Abstract readCase Reports
In one paragraph

Article in Infectious disease reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guido ChiribogaMayo Clinic Alix School of Medicine, Jacksonville, FL 32224, USA.
Qianyu GuoDepartment of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL 32224, USA.
Eric ZuberiDepartment of Internal Medicine, Mayo Clinic Florida, Jacksonville, FL 32224, USA.ORCID 0009-0008-9754-4149
Harry Ross PowersDepartment of Infectious Disease, Mayo Clinic Florida, Jacksonville, FL 32224, USA.ORCID 0000-0002-5308-1575
Libardo Rueda PradaDepartment of Hospital Internal Medicine, Mayo Clinic Florida, Jacksonville, FL 32224, USA.ORCID 0000-0001-6964-5956

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeprosy, caused by CASE PRESENTATION: We report a case of a 62-year-old female with borderline lepromatous leprosy who presented with recurrent facial cellulitis and later developed disseminated ENL. She was initially diagnosed following a series of facial infections and confirmatory skin biopsy. Months later, she developed systemic inflammatory lesions consistent with ENL, requiring hospitalization. She was treated with high-dose corticosteroids for ENL and methotrexate to treat type 1 reaction and continued multidrug therapy (MDT) with minocycline, rifampin, and clarithromycin for leprosy, which led to significant clinical improvement.

conclusionThis case highlights the diagnostic challenges of leprosy in the United States and the importance of recognizing ENL as a severe immunologic complication requiring prompt intervention. A multidisciplinary approach is essential for optimal patient outcomes.

Indexed as

ArmadillosLeprosyLeprosy, LepromatousMycobacterium Infections, NontuberculousMycobacterium leprae

Identifiers

PMID40700329
PMCPMC12285923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.